TCRX · TScan Therapeutics, Inc.
$0.77
+0.00 (+0.23%)
At close · Jul 28
Market Cap
$50.58M
Shares
65.35M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2023-05-16 | $75,000,000 | — | — | — | 10-K , filed 2026-03-04 |